ElevateBio, LLC 4
4 · Allovir, Inc. · Filed Aug 5, 2020
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
ElevateBio, LLC
10% Owner
Transactions
- Conversion
Series A-2 Convertible Preferred Stock
2020-08-03−20,000,000→ 0 total→ Common Stock (13,420,970 underlying) - Conversion
Common Stock
2020-08-03+13,420,970→ 13,420,970 total
Footnotes (2)
- [F1]Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date.
- [F2]Shares held by ElevateBio LLC ("ElevateBio"). David Hallal, Vikas Sinha, Morana Jovan-Embiricos and Ansbert Gadicke are directors of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. Such persons disclaim beneficial ownership of all shares held by ElevateBio except to the extent of their pecuniary interest therein, if any.